Similar articles for PMID: 35110352

Year	Number of Results
2012	1
2015	2
2016	1
2017	2
2020	38
2021	43
2022	9

1

WHO recommends two new drugs to treat COVID-19.

[No authors listed] [No authors listed] Saudi Med J. 2022 Feb;43(2):221. Saudi Med J. 2022. PMID: 35110352 No abstract available.

2

Tutankhamun's Antimalarial Drug for Covid-19.

Sommer AP, Försterling HD, Sommer KE. Sommer AP, et al. Drug Res (Stuttg). 2021 Jan;71(1):4-9. doi: 10.1055/a-1274-1264. Epub 2020 Oct 30. Drug Res (Stuttg). 2021. PMID: 33128226 Free PMC article.

3

Covid-19: WHO recommends baricitinib and sotrovimab to treat patients.

Kmietowicz Z. Kmietowicz Z. BMJ. 2022 Jan 13;376:o97. doi: 10.1136/bmj.o97. BMJ. 2022. PMID: 35027362 No abstract available.

4

Off-Label Use of Chloroquine and Hydroxychloroquine for COVID-19 Treatment in Africa Against WHO Recommendation.

Belayneh A. Belayneh A. Res Rep Trop Med. 2020 Sep 17;11:61-72. doi: 10.2147/RRTM.S269936. eCollection 2020. Res Rep Trop Med. 2020. PMID: 32982538 Free PMC article. Review.

5

WHO recommends corticosteroids for patients with severe or critical COVID-19.

Keyt H. Keyt H. Ann Intern Med. 2021 Jan;174(1):JC2. doi: 10.7326/ACPJ202101190-002. Epub 2021 Jan 5. Ann Intern Med. 2021. PMID: 33395337

6

A living WHO guideline on drugs to prevent covid-19.

Lamontagne F, Agoritsas T, Siemieniuk R, Rochwerg B, Bartoszko J, Askie L, Macdonald H, Amin W, Bausch FJ, Burhan E, Cecconi M, Chanda D, Dat VQ, Du B, Geduld H, Gee P, Nerina H, Hashimi M, Hunt BJ, Kabra S, Kanda S, Kawano-Dourado L, Kim YJ, Kissoon N, Kwizera A, Leo YS, Mahaka I, Manai H, Mino G, Nsutebu E, Pshenichnaya N, Qadir N, Ranganathan SS, Sabzwari S, Sarin R, Sharland M, Shen Y, Souza JP, Stegemann M, Ugarte S, Venkatapuram S, Vuyiseka D, Preller J, Brignardello-Petersen R, Kum E, Qasim A, Zeraatkar D, Owen A, Guyatt G, Lytvyn L, Diaz J, Vandvik PO, Jacobs M. Lamontagne F, et al. BMJ. 2021 Mar 1;372:n526. doi: 10.1136/bmj.n526. BMJ. 2021. PMID: 33649077

7

Nitazoxanide/azithromycin combination for COVID-19: A suggested new protocol for early management.

Kelleni MT. Kelleni MT. Pharmacol Res. 2020 Jul;157:104874. doi: 10.1016/j.phrs.2020.104874. Epub 2020 Apr 30. Pharmacol Res. 2020. PMID: 32360581 Free PMC article.

8

Fluvoxamine and Amantadine: Central Nervous System Acting Drugs Repositioned for COVID-19 as Early Intervention.

Rejdak K, Grieb P. Rejdak K, et al. Curr Neuropharmacol. 2022;20(4):777-781. doi: 10.2174/1570159X19666210729123734. Curr Neuropharmacol. 2022. PMID: 34325642

9

Multipurpose Drugs Active Against Both Plasmodium spp. and Microorganisms: Potential Application for New Drug Development.

Endo T, Takemae H, Sharma I, Furuya T. Endo T, et al. Front Cell Infect Microbiol. 2021 Dec 24;11:797509. doi: 10.3389/fcimb.2021.797509. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 35004357 Free PMC article. Review.

10

Prevalence and predictors of self-medication drugs to prevent or treat COVID-19: Experience from a Middle Eastern country.

Elayeh E, Akour A, Haddadin RN. Elayeh E, et al. Int J Clin Pract. 2021 Nov;75(11):e14860. doi: 10.1111/ijcp.14860. Epub 2021 Sep 19. Int J Clin Pract. 2021. PMID: 34516713 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed